Aveanna Healthcare Holdings Inc. revised revenue guidance for the full Year 2024. For the year, Revenue of greater than $1,970 million, updated from prior guidance of revenue of between $1,960 million and $1,980 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.53 USD | -1.56% |
|
+1.81% | -5.60% |
May. 13 | UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating | MT |
May. 09 | Transcript : Aveanna Healthcare Holdings Inc., Q1 2024 Earnings Call, May 09, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.60% | 494M | |
+17.08% | 82.82B | |
-27.03% | 71.42B | |
-0.14% | 26.41B | |
+2.60% | 17.73B | |
-12.29% | 17.11B | |
+0.35% | 15.43B | |
+74.70% | 13.45B | |
-25.79% | 12.86B | |
+73.31% | 12.63B |
- Stock Market
- Equities
- AVAH Stock
- News Aveanna Healthcare Holdings Inc.
- Aveanna Healthcare Holdings Inc. Revises Revenue Guidance for the Full Year 2024